BLACK DIAMOND THERAPEUTICS I (BDTX)
US09203E1055 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -79.78M | -82.44M | -91.17M | -125.60M | -67.25M | |||
| Depreciation Amortization | 403.00K | 437.00K | 510.00K | 210.00K | 50.00K | |||
| Change In Working Capital | 1.91M | 3.69M | -9.90M | 7.02M | 5.04M | |||
| Other non cash items | 9.60M | 11.60M | 15.48M | 18.22M | 10.01M | |||
| OPERATING CASH FLOW | -67.89M | -66.72M | -85.08M | -100.15M | -52.15M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -33.00K | -190.00K | -2.71M | -140.00K | |||
| Other Investing Activity | -22.16M | 16.38M | 53.56M | 133.32M | -281.55M | |||
| INVESTING CASH FLOW | -22.20M | 16.35M | 53.37M | 130.61M | -281.69M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 76.01M | 71.93M | 180.00K | 730.00K | 214.94M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 76.01M | 71.93M | 180.00K | 730.00K | 214.94M | |||
| CHANGE IN CASH | -14.07M | 21.56M | -31.53M | 31.19M | -118.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -67.89M | -66.72M | -85.08M | -100.15M | -52.15M | |||
| Capital Expenditure | N/A | -33.00K | -190.00K | -2.71M | -140.00K | |||
| FREE CASH FLOW | -67.92M | -66.75M | -85.27M | -102.86M | -52.29M | |||
All data in USD